GW01-200

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameGW01-200
Drug Alias NameGW01-200GW01200GW-01-200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsEsophageal NeoplasmsLeukemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGaowei Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGaowei Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsEsophageal NeoplasmsLeukemia
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A